(19)
(11) EP 2 648 711 A2

(12)

(88) Date of publication A3:
27.09.2012

(43) Date of publication:
16.10.2013 Bulletin 2013/42

(21) Application number: 11847841.1

(22) Date of filing: 05.12.2011
(51) International Patent Classification (IPC): 
A61K 31/16(2006.01)
A61K 31/17(2006.01)
 A61K 31/164(2006.01)
A61P 27/02(2006.01)
(86) International application number:
PCT/US2011/063338
(87) International publication number:
WO 2012/078525 (14.06.2012 Gazette 2012/24)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 06.12.2010 US 420211 P

(71) Applicant: ReVision Therapeutics, Inc.
San Diego, CA 92121 (US)

(72) Inventors:
  • EDGAR, Mark
    Rancho Santa Fe CA 92067 (US)
  • LICHTER, Jay
    San Diego CA 92130 (US)
  • MATA, Nathan L.
    San Diego CA 92130 (US)

(74) Representative: Williams, Richard Andrew Norman 
Harrison Goddard Foote LLP 140 London Wall
London EC2Y 5DN
London EC2Y 5DN (GB)

   


(54) COMPOSITIONS AND METHODS FOR TREATING OPHTHALMIC CONDITIONS